Get the free Erythropoietin Stimulating Agents (ESA) Request Form

Form used to request prior authorization for the use of Erythropoietin Stimulating Agents, detailing patient and physician information, diagnosis, administration details, and required labs.

How to fill out erythropoietin stimulating agents esa

How to fill out Erythropoietin Stimulating Agents (ESA) Request Form

1. Obtain the Erythropoietin Stimulating Agents (ESA) Request Form from the healthcare provider's office or relevant medical department.
2. Fill in the patient's personal information including full name, date of birth, and medical record number.
3. Provide the diagnosis that necessitates the use of ESA, along with any relevant medical history.
4. Indicate the current hemoglobin level and any previous treatments for anemia.
5. Specify the desired treatment regimen, including dosage and frequency of ESA administration.
6. Include any pertinent laboratory results or supporting documentation that justify the request.
7. Sign and date the form, ensuring all required fields are completed before submission.
8. Submit the form to the appropriate department or insurance provider as instructed.

Who needs Erythropoietin Stimulating Agents (ESA) Request Form?

1. Patients diagnosed with anemia related to chronic kidney disease (CKD).
2. Individuals undergoing chemotherapy who experience related anemia.
3. Patients with certain chronic diseases that result in low erythropoietin production.
4. Individuals with anemia due to HIV treatment.
5. Patients prior to elective surgeries with anticipated blood loss.

People Also Ask about

What are the available forms of erythropoietin?

Erythropoietins available for use as therapeutic agents are produced by recombinant DNA technology in cell culture, and include /Procrit ( alfa) and ( alfa); they are used in treating anemia resulting from chronic kidney disease, chemotherapy induced anemia in patients with cancer,

What is ESA EPO?

Erythropoiesis stimulating agents (ESA) are recombinant forms of EPO produced synthetically via recombinant DNA technology in cell cultures. ESAs include alfa, , and methoxy polyethylene glycol- β.[1] ESAs are generally indicated for patients with impaired red blood cell production conditions.

What is ESA erythropoietin?

(eh-RITH-roh-poy-EE-sis-STIM-yoo-LAY-ting AY-jent) A substance that stimulates the bone marrow to make more red blood cells. Erythropoiesis-stimulating agents are used to treat anemia caused by chronic kidney failure, some anticancer drugs, and certain treatments for .

How much does the ESA injection cost?

At the ESA administration level (ie, for each ESA administration), total excess costs were estimated at $128 per in-clinic ESA administration and $7 per at-home ESA administration, excluding monitoring costs.

Is erythropoietin an ESA?

Introduction. Erythropoietin stimulating agents (also called ESA medicines) are used to treat anemia caused by severe kidney disease or chemotherapy for cancer treatment. They may also be used before surgery in some situations.

For pdfFiller’s FAQs

What is Erythropoietin Stimulating Agents (ESA) Request Form?

The Erythropoietin Stimulating Agents (ESA) Request Form is a document used to request authorization for the use of ESAs in patients who require treatment for anemia, particularly in cases associated with chronic kidney disease or cancer.

Who is required to file Erythropoietin Stimulating Agents (ESA) Request Form?

Healthcare providers, such as physicians or authorized healthcare professionals, are required to file the Erythropoietin Stimulating Agents (ESA) Request Form on behalf of the patients who need ESA treatment.

How to fill out Erythropoietin Stimulating Agents (ESA) Request Form?

To fill out the Erythropoietin Stimulating Agents (ESA) Request Form, the healthcare provider must complete all required fields, including patient information, medical history, specific details regarding the anemia diagnosis, and treatment plan, and ensure to provide supporting documentation as needed.

What is the purpose of Erythropoietin Stimulating Agents (ESA) Request Form?

The purpose of the Erythropoietin Stimulating Agents (ESA) Request Form is to facilitate the approval process for the use of ESAs in treating anemic patients by providing necessary medical justification and documentation to the payers.

What information must be reported on Erythropoietin Stimulating Agents (ESA) Request Form?

The Erythropoietin Stimulating Agents (ESA) Request Form must include information such as patient demographics, diagnosis codes, laboratory results (like hemoglobin levels), treatment history, and the rationale for ESA therapy.